Ov101 (gaboxadol)    (DrugBank: Gaboxadol)

1 disease
IDDisease name (Link within this page)Number of trials
206Fragile X syndrome1

206. Fragile X syndrome    [ 98 clinical trials,   73 drugs,   (DrugBank: 27 drugs),   46 drug target genes,   57 drug target pathways]
Searched query = "Fragile X syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 98 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03697161
(ClinicalTrials.gov)
September 17, 20181/10/2018A Study of OV101 in Individuals With Fragile X SyndromeA Phase 2, Randomized, Double-Blind, Parallel-Group Study Evaluating the Safety, Tolerability, and Efficacy of OV101 in Fragile X SyndromeFragile X Syndrome (FXS)Drug: OV101 (gaboxadol)Ovid Therapeutics Inc.NULLCompleted13 Years22 YearsMale23Phase 2United States